Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Status:
Completed
Trial end date:
2014-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety and tolerability of vilazodone
relative to placebo in the treatment of generalized anxiety disorder (GAD)